compounded semaglutide crackdown news november 2025 The FDA announced plans to take action against non-FDA-approved GLP-1 receptor agonists, a move that prompted telehealth company Hims & Hers to yank its new (Wegovy) weight-loss pill from the What Patients Need to Know

Key GLP1 therapies are integrated into national insurance schemes, and the countrys aging population underscores its strategic importance in diabetes and obesity management

For some people, this is not a concern

The connection between weight loss treatments and hair thinning is more nuanced than a simple yes or no, and several factors play a role in whether you might experience shedding

While both drugs offer promising results, no medication is universally better

It is not available through NHS prescribing, nor is it formally listed by any private pharmacy or specialist clinic as an approved treatment option

Are GLP-1 patches FDA-approved